Venlafaxine Hydrochloride (Page 14 of 14)

How should I take venlafaxine tablets?

  • Take venlafaxine tablets exactly as prescribed. Your healthcare provider may need to change the dose of venlafaxine tablets until it is the right dose for you.
  • Venlafaxine tablets are to be taken with food.
  • If you miss a dose of venlafaxine tablets , take the missed dose as soon as you remember. If it is almost time for the next dose, skip the missed dose and take your next dose at the regular time. Do not take two doses of venlafaxine tablets at the same time.
  • If you take too much venlafaxine tablets , call your healthcare provider or poison control center right away, or get emergency treatment.
  • When switching from another antidepressant to venlafaxine tablets your doctor may want to lower the dose of the initial antidepressant first to avoid side effects

What should I avoid while taking venlafaxine tablets?

Venlafaxine tablets can cause sleepiness or may affect your ability to make decisions, think clearly, or react quickly. You should not drive, operate heavy machinery, or do other dangerous activities until you know how venlafaxine tablets affect you. Do not drink alcohol while using venlafaxine tablets.

What are the possible side effects of venlafaxine tablets? Venlafaxine tablets may cause serious side effects, including:

  • See “What is the most important information I should know about venlafaxine tablets ?”
  • Increased cholesterol- have your cholesterol checked regularly
  • Newborns whose mothers take venlafaxine tablets in the third trimester may have problems right after birth including:
  • problems feeding and breathing
  • seizures
  • shaking, jitteriness or constant crying
  • Narrow-angle glaucoma/enlarged pupils. Check eye pressure regularly if you:
  • have a history of increased eye pressure
  • are at risk for certain types of glaucoma

Common possible side effects in people who take venlafaxine tablets include:

  • unusual dreams
  • sexual problems
  • loss of appetite, constipation, diarrhea, nausea or vomiting, or dry mouth
  • feeling tired, fatigued or overly sleepy
  • change in sleep habits, problems sleeping
  • yawning
  • tremor or shaking
  • dizziness, blurred vision
  • sweating
  • feeling anxious, nervous or jittery
  • headache
  • increase in heart rate

Tell your healthcare provider if you have any side effect that bothers you or that does not go away. These are not all the possible side effects of venlafaxine tablets. For more information, ask your healthcare provider or pharmacist.

CALL YOUR DOCTOR FOR MEDICAL ADVICE ABOUT SIDE EFFECTS. YOU MAY REPORT SIDE EFFECTS TO THE FDA AT 1-800-FDA-1088.

How should I store venlafaxine tablets?

  • Store venlafaxine tablets at room temperature between 68°F and 77°F (20°C to 25°C).
  • Keep venlafaxine tablets in a dry place.

Keep venlafaxine tablets and all medicines out of the reach of children.

General information about venlafaxine tablets

Medicines are sometimes prescribed for purposes other than those listed in a Medication Guide. Do not use venlafaxine tablets for a condition for which they were not prescribed. Do not give venlafaxine tablets to other people, even if they have the same condition. They may harm them.

This Medication Guide summarizes the most important information about venlafaxine tablets. If you would like more information, talk with your healthcare provider. You may ask your healthcare provider or pharmacist for information about venlafaxine tablets that is written for healthcare professionals.

For more information about venlafaxine tablets call 1-888-838-2872.

What are the ingredients in venlafaxine tablets?

Active ingredient: venlafaxine hydrochloride.

Inactive ingredients: colloidal silicon dioxide, ferric oxide yellow, ferric oxide red, lactose monohydrate, magnesium stearate, and sodium starch glycolate

All brand names listed are the registered trademarks of their respective owners and are not trademarks of Teva Pharmaceuticals USA, INC.

This Medication Guide has been approved by the U.S. Food and Drug Administration for all antidepressants.

Manufactured In Czech Republic By:
Teva Czech Industries, s.r.o.
Opava-Komarov, Czech Republic

Manufactured For:
Teva Pharmaceuticals USA, Inc.
North Wales, PA 19454

Rev. D 2/2019

Package/Label Display Panel

NDC 0093-9147- 01

VENLAFAXINE Tablets USP

25 mg

SEALED FOR YOUR PROTECTION
PHARMACIST: Dispense the accompanying Medication Guide to each patient.

Rx only

100 TABLETS

TEVA

1
(click image for full-size original)

Package/Label Display Panel

NDC 0093-9148- 01

VENLAFAXINE Tablets USP

37.5 mg

SEALED FOR YOUR PROTECTION
PHARMACIST: Dispense the accompanying Medication Guide to each patient.

Rx only

100 TABLETS

TEVA

1
(click image for full-size original)

Package/Label Display Panel

NDC 0093-9149- 01

VENLAFAXINE Tablets USP

50 mg

SEALED FOR YOUR PROTECTION
PHARMACIST: Dispense the accompanying Medication Guide to each patient.

Rx only

100 TABLETS

TEVA

1
(click image for full-size original)

Package/Label Display Panel

NDC 0093-9157- 01

VENLAFAXINE Tablets USP

75 mg

SEALED FOR YOUR PROTECTION
PHARMACIST: Dispense the accompanying Medication Guide to each patient.

Rx only

100 TABLETS

TEVA

1
(click image for full-size original)

Package/Label Display Panel

NDC 0093-9163- 01

VENLAFAXINE Tablets USP

100 mg

SEALED FOR YOUR PROTECTION
PHARMACIST: Dispense the accompanying Medication Guide to each patient.

Rx only

100 TABLETS

TEVA

1
(click image for full-size original)

VENLAFAXINE HYDROCHLORIDE venlafaxine hydrochloride tablet
Product Information
Product Type HUMAN PRESCRIPTION DRUG Item Code (Source) NDC:0093-9147
Route of Administration ORAL DEA Schedule
Active Ingredient/Active Moiety
Ingredient Name Basis of Strength Strength
VENLAFAXINE HYDROCHLORIDE (VENLAFAXINE) VENLAFAXINE 25 mg
Inactive Ingredients
Ingredient Name Strength
SILICON DIOXIDE
FERRIC OXIDE YELLOW
FERRIC OXIDE RED
LACTOSE MONOHYDRATE
MAGNESIUM STEARATE
SODIUM STARCH GLYCOLATE TYPE A POTATO
Product Characteristics
Color ORANGE (mottled peach) Score 2 pieces
Shape ROUND Size 6mm
Flavor Imprint Code T;V;1;K
Contains
Packaging
# Item Code Package Description Multilevel Packaging
1 NDC:0093-9147-01 100 TABLET in 1 BOTTLE None
Marketing Information
Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date
ANDA ANDA076690 08/04/2006
VENLAFAXINE HYDROCHLORIDE venlafaxine hydrochloride tablet
Product Information
Product Type HUMAN PRESCRIPTION DRUG Item Code (Source) NDC:0093-9148
Route of Administration ORAL DEA Schedule
Active Ingredient/Active Moiety
Ingredient Name Basis of Strength Strength
VENLAFAXINE HYDROCHLORIDE (VENLAFAXINE) VENLAFAXINE 37.5 mg
Inactive Ingredients
Ingredient Name Strength
SILICON DIOXIDE
FERRIC OXIDE YELLOW
FERRIC OXIDE RED
LACTOSE MONOHYDRATE
MAGNESIUM STEARATE
SODIUM STARCH GLYCOLATE TYPE A POTATO
Product Characteristics
Color ORANGE (mottled peach) Score 2 pieces
Shape ROUND Size 7mm
Flavor Imprint Code T;V;2;K
Contains
Packaging
# Item Code Package Description Multilevel Packaging
1 NDC:0093-9148-01 100 TABLET in 1 BOTTLE None
Marketing Information
Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date
ANDA ANDA076690 08/04/2006
VENLAFAXINE HYDROCHLORIDE venlafaxine hydrochloride tablet
Product Information
Product Type HUMAN PRESCRIPTION DRUG Item Code (Source) NDC:0093-9149
Route of Administration ORAL DEA Schedule
Active Ingredient/Active Moiety
Ingredient Name Basis of Strength Strength
VENLAFAXINE HYDROCHLORIDE (VENLAFAXINE) VENLAFAXINE 50 mg
Inactive Ingredients
Ingredient Name Strength
SILICON DIOXIDE
FERRIC OXIDE YELLOW
FERRIC OXIDE RED
LACTOSE MONOHYDRATE
MAGNESIUM STEARATE
SODIUM STARCH GLYCOLATE TYPE A POTATO
Product Characteristics
Color ORANGE (mottled peach) Score 2 pieces
Shape ROUND Size 8mm
Flavor Imprint Code T;V;3;K
Contains
Packaging
# Item Code Package Description Multilevel Packaging
1 NDC:0093-9149-01 100 TABLET in 1 BOTTLE None
Marketing Information
Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date
ANDA ANDA076690 08/04/2006
VENLAFAXINE HYDROCHLORIDE venlafaxine hydrochloride tablet
Product Information
Product Type HUMAN PRESCRIPTION DRUG Item Code (Source) NDC:0093-9157
Route of Administration ORAL DEA Schedule
Active Ingredient/Active Moiety
Ingredient Name Basis of Strength Strength
VENLAFAXINE HYDROCHLORIDE (VENLAFAXINE) VENLAFAXINE 75 mg
Inactive Ingredients
Ingredient Name Strength
SILICON DIOXIDE
FERRIC OXIDE YELLOW
FERRIC OXIDE RED
LACTOSE MONOHYDRATE
MAGNESIUM STEARATE
SODIUM STARCH GLYCOLATE TYPE A POTATO
Product Characteristics
Color ORANGE (mottled peach) Score 2 pieces
Shape ROUND Size 10mm
Flavor Imprint Code T;V;4;K
Contains
Packaging
# Item Code Package Description Multilevel Packaging
1 NDC:0093-9157-01 100 TABLET in 1 BOTTLE None
Marketing Information
Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date
ANDA ANDA076690 08/04/2006
VENLAFAXINE HYDROCHLORIDE venlafaxine hydrochloride tablet
Product Information
Product Type HUMAN PRESCRIPTION DRUG Item Code (Source) NDC:0093-9163
Route of Administration ORAL DEA Schedule
Active Ingredient/Active Moiety
Ingredient Name Basis of Strength Strength
VENLAFAXINE HYDROCHLORIDE (VENLAFAXINE) VENLAFAXINE 100 mg
Inactive Ingredients
Ingredient Name Strength
SILICON DIOXIDE
FERRIC OXIDE YELLOW
FERRIC OXIDE RED
LACTOSE MONOHYDRATE
MAGNESIUM STEARATE
SODIUM STARCH GLYCOLATE TYPE A POTATO
Product Characteristics
Color ORANGE (mottled peach) Score 2 pieces
Shape ROUND Size 10mm
Flavor Imprint Code T;V;5;K
Contains
Packaging
# Item Code Package Description Multilevel Packaging
1 NDC:0093-9163-01 100 TABLET in 1 BOTTLE None
Marketing Information
Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date
ANDA ANDA076690 08/04/2006
Labeler — Teva Pharmaceuticals USA, Inc. (001627975)

Revised: 05/2020 Teva Pharmaceuticals USA, Inc.

All MedLibrary.org resources are included in as near-original form as possible, meaning that the information from the original provider has been rendered here with only typographical or stylistic modifications and not with any substantive alterations of content, meaning or intent.

This site is provided for educational and informational purposes only, in accordance with our Terms of Use, and is not intended as a substitute for the advice of a medical doctor, nurse, nurse practitioner or other qualified health professional.

Privacy Policy | Copyright © 2020. All Rights Reserved.